Filing Flows

Filing Flows › Dianthus Therapeutics (DNTH) › Who owns the stock

Who owns Dianthus Therapeutics (DNTH) stock

254 funds reported Dianthus Therapeutics (DNTH) shares in their latest 13F filings, worth $6.4B in all. The largest holder is FMR LLC ($799M). Last quarter 156 funds added to their stakes and 96 cut them.

Largest holders of DNTH (13F)Largest holders of DNTH (13F)FMR LLC$799MBlackRock$402MT. Rowe Price Investment Manageme…$379MWellington Management Group LLP$315MFairmount Funds Management LLC$247MPrice T Rowe Associates$245MState Street$230MVanguard Capital Management LLC$211MAvidity Partners Management LP$205MOctagon Capital Advisors LP$180M

Largest holders (13F)

FundSharesValueChangeQuarter
FMR LLC8,199,893$799Mincrease2026-06-30
BlackRock4,123,822$402Mincrease2026-06-30
T. Rowe Price Investment Management3,888,456$379Mincrease2026-06-30
Wellington Management Group LLP3,229,882$315Mincrease2026-06-30
Fairmount Funds Management LLC2,537,191$247Munchanged2026-06-30
Price T Rowe Associates2,514,946$245Mincrease2026-06-30
State Street2,357,440$230Mincrease2026-06-30
Vanguard Capital Management LLC2,159,568$211Mincrease2026-06-30
Avidity Partners Management LP2,104,184$205Mdecrease2026-06-30
Octagon Capital Advisors LP1,841,667$180Mdecrease2026-06-30
TCG Crossover Management, LLC1,676,624$163Munchanged2026-06-30
Fred Alger Management, LLC1,302,493$127Mincrease2026-06-30
Geode Capital Management, LLC1,258,502$123Mincrease2026-06-30
VR Adviser, LLC1,180,000$115Munchanged2026-06-30
UBS Group AG1,140,260$111Mincrease2026-06-30

Dianthus Therapeutics' latest quarter

Dianthus Therapeutics, Q4 2025: revenue $284K (-79% year over year), net loss $64.4M, operating cash flow −$47.0M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most DNTH stock?

By the latest 13F filings: FMR LLC ($799M); BlackRock ($402M); T. Rowe Price Investment Management ($379M); Wellington Management Group LLP ($315M); Fairmount Funds Management LLC ($247M).

What is the short interest in DNTH?

8,986,958 shares were sold short at the 2026-10-15 settlement, -1.68% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.